# diabetes-agent-daily-v2 log

2026-09-30 | Week-ahead CGM hypoglycemia risk + care nudge (GVU) | Smoke-tested sample P-204: pass1 moderate/43.5 failed verifier; pass2 high/61.5 passed.
2026-10-01 | Monthly-calibrated PPG + implicit HbA1c GVU | Smoke-tested P-088 oral_add: pass1 MARD 18.9% fail; pass2 10.0% pass after IR/pretest mix update.
2026-10-02 | Phenotype-routed lifestyle dose GVU | Smoke-tested P-310 high-BMI/IR/FTO-risk: pass1 20min/restraint 4 failed; pass2 40min/restraint 7 passed.
2026-10-03 | Next-day SMBG+BP hypoglycemia flag | Smoke-tested P-441: pass1 low/22 failed verifier; pass2 high/87 passed with SBP-drop feature and carb plan.
2026-10-04 | 14-day silent prediabetes curve-feature screen | Smoke-tested P-514: pass1 normoglycemia/step_count failed; pass2 prediabetes/0.94 passed with fasting_proxy, peak_delta, recovery_slope.
2026-10-05 | BCT-constrained glycemic nudge (problem solving + reward/threat) | Smoke-tested P-605: pass1 self-monitor-only failed; pass2 obstacle branch + coffee contingency passed.
2026-10-06 | Context-horizon hypo gate (IOB + carb residual + activity, 60 min) | Smoke-tested P-718: pass1 slope-only failed; pass2 high/1.0 with 15 g correction passed.
2026-10-07 | CGM vs Gold awareness discordance flag (GVU) | Smoke-tested P-807: pass1 low/routine_followup failed; pass2 high_discordance/caregiver_check passed.
2026-10-08 | Composite-outcome DPP closer (missing limb gate) | Smoke-tested P-908: pass1 activity nudge failed (limb already met); pass2 weight-loss gap 3.37 passed.
2026-10-09 | Breath-acetone LOD + interferent selectivity gate | Smoke-tested BR-1009: pass1 diabetes_screen/LOD 3.26 failed; pass2 prediabetes_screen/LOD 1.087 passed.
2026-10-10 | Dual-site 8-min PPG concordance gate (wrist vs in-ear) | Smoke-tested P-1010: pass1 normal/wrist-only failed; pass2 elevated_glucose_risk/0.645 passed.
2026-10-11 | Feature-driven weekly CGM hypo risk + actionable nudge (LBGI/TBR gate) | Smoke-tested P-1111: pass1 generic nudge failed; pass2 high/78.0 with nocturnal carb correction passed.
2026-10-14 | Week-ahead CGM hypo risk + specific nocturnal nudge (GVU) | Smoke-tested P-1410: pass1 generic/63.8 failed; pass2 high/79.0 with 15g nocturnal carb passed.
2026-10-15 | Smartphone-camera PPG digital biomarker GVU for diabetes detection (long-range context) | Smoke-tested P-1510: pass1 0.65 missing long-range failed; pass2 0.80 + long_range_context_10min passed.
2026-10-16 | PPG digital biomarker GVU for early detection with long-range temporal features | Smoke-tested sample: pass1 short_segment failed verifier; pass2 long_range_context_10min with score 0.80 passed.
2026-10-18 | Phenotype-routed lifestyle dose GVU (BMI/IR/FTO) for digital therapeutics | Smoke-tested P-1810: pass1 conservative 15min/restr4 drop0.15 failed; pass2 40min/restr6 drop0.83 passed.
2026-10-19 | PPG + demographics non-invasive elevated glucose risk screen with long-range temporal context (GVU) | Smoke-tested P-1910: pass1 0.92 missing temporal failed; pass2 0.97 + long_range_context passed.
2026-10-21 | PPG+demo early detection with heuristic consistency GVU | Smoke-tested high-risk sample: pass1 score valid and consistent, kept as minimal triage prototype.
2026-10-22 | Explainable CGM hypo/hyper risk + SHAP-style actionable explanation (GVU) | Smoke-tested P-2210: pass1 score 100 with slope+TBR + 15g carb passed verifier on first pass.
2026-10-23 | Dual-channel HOMA-IR aptasensor early IR detection (GVU) | Smoke-tested: pass1 glucose_only/42.0 failed; pass2 dual-channel/68.5 high_prediabetes passed.
2026-10-24 | Multi-modal wearable (slope+GSR+activity+TBR) hypo risk flag + specific nudge (GVU) | Smoke-tested high-risk sample: pass1 score 100/high + 15g carb nudge passed verifier on first pass.
2026-10-25 | Explainable CGM hypo risk + nocturnal SHAP-style nudge (GVU) | Smoke-tested high-TBR sample: pass1 moderate/60.0 missing nocturnal failed; pass2 with nocturnal carb nudge passed.
2026-10-26 | Unconstrained wearable CGM+inertial prediabetes detection (dynamic+curve features GVU) | Smoke-tested high-risk sample: pass1 0.65/normoglycemia failed; pass2 0.85/prediabetes passed after boost.
2026-10-27 | Week-ahead CGM hypo risk + specific nocturnal nudge (GVU) | Smoke-tested TBR=5.2%: pass1 high/75.7 generic failed; pass2 high/85.7 with 15g carb passed.
